Name: BRISTOL-MYERS SQUIBB CO (BRM) Stock
Brand: BRISTOL-MYERS SQUIBB CO
Rating: 6.5 (3 reviews)

Question 1

What does BRM do?

Accepted Answer

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The company is headquartered in Princeton, New Jersey and currently employs 34,100 full-time employees.  The company is engaged in the discovery, development and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Opdualag (nivolumab and relatlimab-rmbw), Breyanzi (lisocabtagene maraleucel), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), and Sotyktu (deucravacitinib). Its other growth products include Onureg, Inrebic, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension). Opdivo (nivolumab) is a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells.

Question 2

What is the current price of BRM stock?

Accepted Answer

The current stock price of BRM.DE is 45.355 EUR. The price increased by 1.36% in the last trading session.

Question 3

Does BRISTOL-MYERS SQUIBB CO pay dividends?

Accepted Answer

BRISTOL-MYERS SQUIBB CO (BRM.DE) has a dividend yield of 4.92%. The yearly dividend amount is currently 2.06.

Question 4

What is the ChartMill technical and fundamental rating of BRM stock?

Accepted Answer

BRM.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.

Question 5

On which exchange is BRM.DE stock listed?

Accepted Answer

BRM.DE stock is listed on the Frankfurt Stock Exchange exchange.

Question 6

Should I buy BRM stock?

Accepted Answer

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BRM.DE.

Question 7

What is the market capitalization of BRM stock?

Accepted Answer

BRISTOL-MYERS SQUIBB CO (BRM.DE) has a market capitalization of 92.33B EUR. This makes BRM.DE a Large Cap stock.

BRISTOL-MYERS SQUIBB CO (BRM.DE) Stock Price, Forecast & Analysis

BRM.DE Latest News, Press Relases and Analysis